In brief
On 3 October, Nigeria confirmed its first Ebola case—a 42‑year‑old woman who had returned from a holiday in Kampala, Uganda. She fell ill three days after arriving in Abuja, prompting health authorities to isolate 44 contacts and begin an intensive tracing effort. The patient, a diplomat’s wife, also stopped briefly in Addis Ababa, Ethiopia, leading to a cross‑border investigation by the African CDC. While the patient remains stable, the outbreak follows the ongoing resurgence in the Democratic Republic of Congo and underscores the need for regional solidarity and vigilant surveillance.
Nigeria’s deadly first Ebola case was confirmed on 3 October, a 42‑year‑old woman who had just returned from a holiday in Kampala, Uganda.
The patient, a diplomat’s wife and originally from Uganda, had spent two and a half weeks in the capital before flying back to Abuja, where she fell ill three days after arrival.
She also made a short stopover in Addis Ababa, Ethiopia, on her return flight – a detail that has triggered a cross‑border investigation by the Africa Centres for Disease Control and Prevention.
Nigeria’s Health Minister, Muhammad Ali Pate, said the patient was stable and improving while authorities worked to contain the virus. The Ministry has identified 44 people who were close enough to be at risk; all are now in isolation and show no symptoms.
The outbreak in the Democratic Republic of Congo began in May and has already claimed more than 4 600 deaths, with over 9 500 confirmed cases worldwide.
“We respect our sister nation of Uganda,” Pate added, stressing that Nigeria, Uganda, Ethiopia and the Africa CDC are collaborating to fully trace the patient’s journey and prevent further spread.
The United States has urged its citizens to reconsider travel to Kenya and has raised its travel advisory level for the country after new cases emerged.
Nigeria had successfully contained an Ebola outbreak in 2014, which yielded 20 confirmed cases and eight deaths, giving officials confidence that experience can help stop the current surge.
The current strain is the Bundibugyo species, for which no vaccine or treatment is yet approved, but trials are underway. Africa’s public‑health infrastructure remains strained, underscoring the importance of regional cooperation.
